Molecular and Immune Landscape of Melanoma: A Risk Stratification Model for Precision Oncology

Investigators provided a robust immune-related prognostic model for melanoma. They underscored the value of immune gene expression and T cell infiltration, particularly CD8⁺ T cells, in predicting patient outcomes.